LINCOLN PHARMACEUTICALS LTD. - 531633 - Financial Result For The Quarter And Half Year Ended September 30, 2020
we would like to inform that the Board of Directors of the Company at their meeting held today i.e. Tuesday, November 03, 2020, have considered and approved the Un-Audited Financial Results of the Company (Standalone and Consolidated) along with the limited review report for the Quarter and Half Year Ended on September 30, 2020. LINCOLN PHARMACEUTICALS LTD. - 531633 - Outcome Of Board Meeting
we would like to inform that the Board of Directors of the Company at their meeting held today i.e. Tuesday, November 03, 2020, have considered and approved the Un-Audited Financial Results of the Company (Standalone and Consolidated) along with the limited review report for the Quarter and Half Year Ended on September 30, 2020. We also enclose herewith financial highlights of the Company for the aforesaid quarter. LINCOLN PHARMACEUTICALS LTD. - 531633 - Chairman''s Report Along With Scrutinizer''s Report Of NCLT Convened Meetings Held On October 29, 2020.
Chairman''s Report along with Scrutinizer''s Report of NCLT Convened Meeting of Members of the Company. LINCOLN PHARMACEUTICALS LTD. - 531633 - Disclosure of Voting results of Court Convened Meeting (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Lincoln Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of Court Convened Meeting, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here LINCOLN PHARMACEUTICALS LTD. - 531633 - E-Voting Result Along With Scrutinizer''''s Report Of Court Conveyed Meeting
E-Voting Result along with Scrutinizer''''s Report of the National Company Law Tribunal Convened Meeting of Members of Lincoln Pharmaceuticals Limited as per Regulation 44 of SEBI (LODR) Regulations 2015. LINCOLN PHARMACEUTICALS LTD. - 531633 - Proceedings Of The National Company Law Tribunal Convened Meeting Of Members Of The Company
Proceedings of the National Company Law Tribunal Convened Meeting of Members of Lincoln Pharmaceuticals Limited as per Regulation 30 of SEBI (LODR) Regulations 2015 LINCOLN PHARMACEUTICALS LTD. - 531633 - Minutes Of Meeting Of 26Th Annual General Meeting Of The Company.
Submission of Minutes of the 26th Annual General Meeting of the Company. LINCOLN PHARMACEUTICALS LTD. - 531633 - Board Meeting Intimation for Inter-Alia To Consider And Approve The Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Half Year Ended On September 30, 2020.
LINCOLN PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2020 ,inter alia, to consider and approve the Un-Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended on September 30, 2020 along with any other business, if any. Further, in continuation to our disclosure on closure of trading window dated September 30, 2020, the trading window for dealing / trading in the securities of the Company by the designated persons was closed from October 01, 2020 and shall remain closed till 48 hours after the announcement of financials results. LINCOLN PHARMACEUTICALS LTD. - 531633 - Compliance Certificate Under Regulation 40 (9) For The Half Year Ended September 30, 2020
Half Yearly Compliance Certificate for the Period Ended on September 30, 2020 as required under Regulation 40 (9) of SEBI (Listing and Obligations Requirements) Regulations, 2015. LINCOLN PHARMACEUTICALS LTD. - 531633 - Compliance Certificate Under Regulation 7 (3) For The Half Year Ended September 30, 2020
Compliance Certificate Under Regulation 7 (3) of SEBI (LODR) Regulations, 2015 for the Period Ended September 30, 2020.